Hilltop Holdings Inc. bought a new position in Stryker Co. (NYSE:SYK) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 1,011 shares of the medical technology company’s stock, valued at approximately $212,000.
A number of other hedge funds have also bought and sold shares of the business. ERTS Wealth Advisors LLC bought a new position in Stryker during the fourth quarter valued at about $25,000. Princeton Global Asset Management LLC bought a new stake in shares of Stryker during the 4th quarter worth about $29,000. Evolution Wealth Advisors LLC bought a new stake in shares of Stryker during the 4th quarter worth about $33,000. Lloyd Advisory Services LLC. acquired a new position in shares of Stryker during the 4th quarter valued at about $33,000. Finally, Hudock Capital Group LLC increased its holdings in shares of Stryker by 123.5% during the 4th quarter. Hudock Capital Group LLC now owns 181 shares of the medical technology company’s stock valued at $38,000 after acquiring an additional 100 shares during the last quarter. 73.10% of the stock is owned by institutional investors.
Several research firms recently weighed in on SYK. Piper Sandler lowered Stryker from an “overweight” rating to a “neutral” rating and set a $210.00 target price for the company. in a report on Tuesday, January 7th. Deutsche Bank upped their target price on Stryker from $239.00 to $243.00 and gave the stock a “buy” rating in a research report on Wednesday, January 29th. Zacks Investment Research upgraded Stryker from a “hold” rating to a “buy” rating and set a $215.00 price target on the stock in a report on Thursday, November 28th. Stifel Nicolaus dropped their price target on shares of Stryker from $250.00 to $145.00 and set a “buy” rating on the stock in a research report on Tuesday. Finally, BTIG Research restated a “buy” rating on shares of Stryker in a research note on Thursday, January 30th. Seven analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $220.81.
SYK opened at $153.05 on Thursday. The business has a 50 day moving average of $191.15 and a 200-day moving average of $205.62. The stock has a market capitalization of $53.73 billion, a price-to-earnings ratio of 27.93, a P/E/G ratio of 1.56 and a beta of 0.80. The company has a current ratio of 2.58, a quick ratio of 1.84 and a debt-to-equity ratio of 0.80. Stryker Co. has a 1-year low of $124.54 and a 1-year high of $226.30.
Stryker (NYSE:SYK) last announced its earnings results on Tuesday, January 28th. The medical technology company reported $2.49 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.46 by $0.03. The business had revenue of $4.13 billion for the quarter, compared to analyst estimates of $4.11 billion. Stryker had a net margin of 13.99% and a return on equity of 25.75%. Stryker’s revenue was up 8.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.18 earnings per share. Equities analysts predict that Stryker Co. will post 9.11 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Thursday, April 30th. Investors of record on Tuesday, March 31st will be paid a $0.575 dividend. This represents a $2.30 annualized dividend and a dividend yield of 1.50%. The ex-dividend date of this dividend is Monday, March 30th. Stryker’s payout ratio is presently 27.85%.
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.
Recommended Story: How liquidity affects the bid-ask spread
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.